Literature DB >> 10557293

Monitoring the assembly of Ig light-chain amyloid fibrils by atomic force microscopy.

C Ionescu-Zanetti1, R Khurana, J R Gillespie, J S Petrick, L C Trabachino, L J Minert, S A Carter, A L Fink.   

Abstract

Aggregation of Ig light chains to form amyloid fibrils is a characteristic feature of light-chain amyloidosis, a light-chain deposition disease. A recombinant variable domain of the light chain SMA was used to form amyloid fibrils in vitro. Fibril formation was monitored by atomic force microscopy imaging. Single filaments 2.4 nm in diameter were predominant at early times; protofibrils 4.0 nm in diameter were predominant at intermediate times; type I and type II fibrils 8.0 nm and 6.0 nm in diameter, respectively, were predominant at the endpoints. The increase in number of fibrils correlated with increased binding of the fluorescent dye thioflavin T. The fibrils and protofibrils showed a braided structure, suggesting that their formation involves the winding of protofibrils and filaments, respectively. These observations support a model in which two filaments combine to form a protofibril, two protofibrils intertwine to form a type I fibril, and three filaments form a type II fibril.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10557293      PMCID: PMC23920          DOI: 10.1073/pnas.96.23.13175

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Watching amyloid fibrils grow by time-lapse atomic force microscopy.

Authors:  C Goldsbury; J Kistler; U Aebi; T Arvinte; G J Cooper
Journal:  J Mol Biol       Date:  1999-01-08       Impact factor: 5.469

2.  Adsorption of biological molecules to a solid support for scanning probe microscopy.

Authors:  D J Müller; M Amrein; A Engel
Journal:  J Struct Biol       Date:  1997-07       Impact factor: 2.867

Review 3.  Properties of biomolecules measured from atomic force microscope images: a review.

Authors:  H G Hansma; K J Kim; D E Laney; R A Garcia; M Argaman; M J Allen; S M Parsons
Journal:  J Struct Biol       Date:  1997-07       Impact factor: 2.867

4.  Observation of metastable Abeta amyloid protofibrils by atomic force microscopy.

Authors:  J D Harper; S S Wong; C M Lieber; P T Lansbury
Journal:  Chem Biol       Date:  1997-02

5.  Creation of "amyloid" fibrils from Bence Jones proteins in vitro.

Authors:  G G Glenner; D Ein; E D Eanes; H A Bladen; W Terry; D L Page
Journal:  Science       Date:  1971-11-12       Impact factor: 47.728

6.  Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein.

Authors:  J D Harper; C M Lieber; P T Lansbury
Journal:  Chem Biol       Date:  1997-12

7.  Variable domain structure of kappaIV human light chain Len: high homology to the murine light chain McPC603.

Authors:  D B Huang; C H Chang; C Ainsworth; G Johnson; A Solomon; F J Stevens; M Schiffer
Journal:  Mol Immunol       Date:  1997-12       Impact factor: 4.407

8.  Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.

Authors:  K A Conway; J D Harper; P T Lansbury
Journal:  Nat Med       Date:  1998-11       Impact factor: 53.440

9.  The characterization of soluble amyloid prepared in water.

Authors:  M Pras; M Schubert; D Zucker-Franklin; A Rimon; E C Franklin
Journal:  J Clin Invest       Date:  1968-04       Impact factor: 14.808

10.  High-resolution electron microscopic analysis of the amyloid fibril.

Authors:  T Shirahama; A S Cohen
Journal:  J Cell Biol       Date:  1967-06       Impact factor: 10.539

View more
  48 in total

1.  Ultrastructural organization of amyloid fibrils by atomic force microscopy.

Authors:  A K Chamberlain; C E MacPhee; J Zurdo; L A Morozova-Roche; H A Hill; C M Dobson; J J Davis
Journal:  Biophys J       Date:  2000-12       Impact factor: 4.033

2.  A systematic exploration of the influence of the protein stability on amyloid fibril formation in vitro.

Authors:  M Ramirez-Alvarado; J S Merkel; L Regan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

3.  Conformational characterization of oligomeric intermediates and aggregates in beta-lactoglobulin heat aggregation.

Authors:  R Carrotta; R Bauer; R Waninge; C Rischel
Journal:  Protein Sci       Date:  2001-07       Impact factor: 6.725

4.  The protofilament structure of insulin amyloid fibrils.

Authors:  José L Jiménez; Ewan J Nettleton; Mario Bouchard; Carol V Robinson; Christopher M Dobson; Helen R Saibil
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-01       Impact factor: 11.205

5.  Theoretical modeling of prion disease incubation.

Authors:  R V Kulkarni; A Slepoy; R R P Singh; D L Cox; F Pázmándi
Journal:  Biophys J       Date:  2003-08       Impact factor: 4.033

6.  A general model for amyloid fibril assembly based on morphological studies using atomic force microscopy.

Authors:  Ritu Khurana; Cristian Ionescu-Zanetti; Maighdlin Pope; Jie Li; Liza Nielson; Marina Ramírez-Alvarado; Lynn Regan; Anthony L Fink; Sue A Carter
Journal:  Biophys J       Date:  2003-08       Impact factor: 4.033

7.  A kinetic study of beta-lactoglobulin amyloid fibril formation promoted by urea.

Authors:  Daizo Hamada; Christopher M Dobson
Journal:  Protein Sci       Date:  2002-10       Impact factor: 6.725

8.  Transient formation of nano-crystalline structures during fibrillation of an Abeta-like peptide.

Authors:  Daniel E Otzen; Mikael Oliveberg
Journal:  Protein Sci       Date:  2004-05       Impact factor: 6.725

9.  Reverse engineering an amyloid aggregation pathway with dimensional analysis and scaling.

Authors:  J Bailey; K J Potter; C B Verchere; L Edelstein-Keshet; D Coombs
Journal:  Phys Biol       Date:  2011-11-25       Impact factor: 2.583

10.  A generic crystallization-like model that describes the kinetics of amyloid fibril formation.

Authors:  Rosa Crespo; Fernando A Rocha; Ana M Damas; Pedro M Martins
Journal:  J Biol Chem       Date:  2012-07-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.